Published in BMC Cancer on December 10, 2009
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B. Cancer Med (2012) 0.95
The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics (2010) 0.92
The PI3K/Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells. BMC Cancer (2010) 0.89
Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways. J Transl Med (2013) 0.86
Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms. Cancer Cell Int (2014) 0.82
Expression of Id-1 and VEGF in non-small cell lung cancer. Int J Clin Exp Pathol (2013) 0.78
Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity. Cancer Gene Ther (2015) 0.77
Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer. Genes Cancer (2014) 0.77
ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes. Histochem Cell Biol (2013) 0.76
Serum regulation of Id1 expression by a BMP pathway and BMP responsive element. Biochim Biophys Acta (2013) 0.76
Epigenetic regulation of transcription factor promoter regions by low-dose genistein through mitogen-activated protein kinase and mitogen-and-stress activated kinase 1 nongenomic signaling. Cell Commun Signal (2016) 0.76
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (1992) 18.26
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol (1996) 15.20
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature (1999) 6.50
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med (1985) 5.82
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature (2001) 4.14
Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer (2005) 3.80
Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol (1997) 2.71
Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol (1998) 2.64
Id proteins in cell growth and tumorigenesis. Cancer Cell (2003) 2.38
The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res (1994) 2.07
Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci U S A (2001) 1.98
Id proteins in cell cycle control and cellular senescence. Oncogene (2001) 1.88
A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res (2000) 1.83
The Id proteins and angiogenesis. Oncogene (2001) 1.70
Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A (2003) 1.68
Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci U S A (1999) 1.47
Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell (2002) 1.42
Coupling of cell growth control and apoptosis functions of Id proteins. Mol Cell Biol (1998) 1.41
Id genes and proteins as promising targets in cancer therapy. Trends Mol Med (2004) 1.33
Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol (1999) 1.33
Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res (2003) 1.32
Over expression of ID-1 in prostate cancer. J Urol (2002) 1.31
Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol (2004) 1.25
Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis (2005) 1.24
Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer (1996) 1.24
Id-1 expression and cell survival. Apoptosis (2004) 1.16
Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma. Br J Cancer (2007) 1.09
Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res (2007) 1.06
Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci (2005) 1.05
Mutually exclusive expression of two dominant-negative helix-loop-helix (dnHLH) genes, Id4 and Id3, in the developing brain of the mouse suggests distinct regulatory roles of these dnHLH proteins during cellular proliferation and differentiation of the nervous system. Cell Growth Differ (1995) 1.05
The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer (2001) 1.02
Id proteins--tumor markers or oncogenes? Cancer Biol Ther (2002) 1.01
Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis (2002) 0.99
Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases. Mod Pathol (2006) 0.99
Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis (2004) 0.97
Expression of helix-loop-helix factor Id-1 is dependent on the hepatocyte proliferation and differentiation status in rat liver and in primary culture. Cancer Res (1994) 0.94
Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int J Cancer (2006) 0.91
Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett (2006) 0.91
The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells. Oncol Rep (2005) 0.86
Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers. Br J Cancer (2008) 0.86
Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer. Int J Cancer (2006) 0.81
Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer. Cancer Sci (2006) 0.77
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol (2008) 3.27
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol (2002) 2.61
A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation. Hepatology (2005) 1.97
Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg (2007) 1.35
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci (2004) 1.34
Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology (2005) 1.33
Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer (2003) 1.32
Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut (2006) 1.31
LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett (2006) 1.30
Coexpression of Gas6/Axl in human ovarian cancers. Oncology (2004) 1.23
Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol (2007) 1.15
Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse. J Exp Med (2004) 1.12
Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med (2008) 1.09
Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. J Hepatol (2007) 1.06
Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model. Hepatology (2003) 1.04
Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci (2009) 1.04
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci (2004) 1.03
Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. Genes Cells (2004) 1.00
The impact of 3-D virtual hepatectomy simulation in living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.00
Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol (2009) 0.99
Microbiology of Bartholin's gland abscess in Japan. J Clin Microbiol (2005) 0.97
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology (2013) 0.96
Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol Pharm Bull (2004) 0.96
Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice. J Hepatol (2006) 0.95
Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids (2003) 0.94
Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J Steroid Biochem Mol Biol (2007) 0.94
Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers. Oncology (2004) 0.93
Osteopontin in metastatic lesions as a prognostic marker in ovarian cancers. J Biomed Sci (2007) 0.93
Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol (2005) 0.91
Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int (2002) 0.91
Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats. Am J Pathol (2007) 0.90
Clinical implication of estrogen-related receptor (ERR) expression in ovarian cancers. J Steroid Biochem Mol Biol (2007) 0.90
Hepatocyte growth factor improves survival after partial hepatectomy in cirrhotic rats suppressing apoptosis of hepatocytes. Surgery (2008) 0.90
Hemodynamic analysis and treatment of an enlarging extrahepatic portal aneurysm: report of a case. Surg Today (2014) 0.90
Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today (2005) 0.90
New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. J Gastroenterol (2013) 0.89
Penetration of ravuconazole, a new triazole antifungal, into rat tissues. Chemotherapy (2002) 0.89
Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol (2004) 0.88
Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20. Pancreas (2009) 0.88
Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K-Akt pathway. Lab Invest (2011) 0.87
Role of innate immune response in liver regeneration. J Gastroenterol Hepatol (2007) 0.87
Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci (2010) 0.87
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers. Gynecol Oncol (2009) 0.87
Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol (2003) 0.87
TLRs, NF-κB, JNK, and Liver Regeneration. Gastroenterol Res Pract (2010) 0.86
Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther (2006) 0.86
Sex steroid-dependent angiogenesis in uterine endometrial cancers. J Steroid Biochem Mol Biol (2005) 0.86
Laparoscopic management of giant splenic true cyst with partial splenectomy: a case report. Asian J Endosc Surg (2013) 0.86
Safety of hepatic resection for hepatocellular carcinoma in obese patients with cirrhosis. Surg Today (2013) 0.85
Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count. Hepatol Res (2013) 0.85
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice. Gastroenterol Res Pract (2010) 0.85
Primary squamous cell carcinoma of the liver: an uncommon finding in contrast-enhanced ultrasonography imaging. Case Rep Gastroenterol (2011) 0.85
Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood (2004) 0.85
Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Int J Oncol (2005) 0.84
c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells. Cancer Sci (2011) 0.84
Strategy of gene therapy for liver cirrohosis and hepatocellular carcinoma. J Hepatobiliary Pancreat Surg (2003) 0.84
Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci (2003) 0.84
Minimally invasive laparoscopic liver resection: 3D MDCT simulation for preoperative planning. J Hepatobiliary Pancreat Surg (2009) 0.84
Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamine-induced liver fibrosis in rats. Hepatol Res (2008) 0.83
Adeno-associated virus vector-mediated production of hepatocyte growth factor attenuates liver fibrosis in mice. Hepatol Int (2007) 0.83
Angiogenesis is crucial for liver regeneration after partial hepatectomy. Surgery (2012) 0.83
Expression screening of 17q12-21 amplicon reveals GRB7 as an ERBB2-dependent oncogene. FEBS Lett (2012) 0.83
Translocation of lysophosphatidic acid phosphatase in response to gonadotropin-releasing hormone to the plasma membrane in ovarian cancer cell. Am J Obstet Gynecol (2004) 0.83
Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Oncology (2008) 0.82
Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers. Cancer Lett (2006) 0.82
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci (2003) 0.82
Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Gynecol Oncol (2004) 0.82
Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatol Res (2011) 0.82
Estrogen-related receptor expression in placenta throughout gestation. J Steroid Biochem Mol Biol (2005) 0.82
Granulocyte-colony stimulating factor-producing gallbladder carcinoma. Int Surg (2014) 0.81
Direct protection by a gonadotropin-releasing hormone analog from doxorubicin-induced granulosa cell damage. Gynecol Obstet Invest (2006) 0.81
Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. Oncol Rep (2006) 0.81
Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate. J Infect Chemother (2008) 0.80
[Two cases of Bartholin's gland abscesses caused by Streptococcus pneumoniae and Haemophilus influenzae]. Jpn J Antibiot (2005) 0.80
Uterine contractions might increase heart preload in the recipient fetus in early-onset twin-twin transfusion syndrome: an ultrasound assessment. Prenat Diagn (2004) 0.80
Reactive oxygen species modify oligosaccharides of glycoproteins in vivo: a study of a spontaneous acute hepatitis model rat (LEC rat). Biochem Biophys Res Commun (2006) 0.80
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer. Oncol Rep (2006) 0.80
Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers. J Biomed Sci (2006) 0.80
Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology (2002) 0.80
Successful liver resection for biliary atresia with intrahepatic biliary cysts after Kasai procedure. J Pediatr Surg (2005) 0.80
Successful living related liver transplantation for adult Still's disease. J Gastroenterol Hepatol (2003) 0.79
Multivariate logistic regression analysis for prediction of clinically relevant pancreatic fistula in the early phase after pancreaticoduodenectomy. J Hepatobiliary Pancreat Sci (2013) 0.79
Frequent polymorphic changes but rare tumor specific mutations of the LATS2 gene on 13q11-12 in esophageal squamous cell carcinoma. Int J Oncol (2002) 0.79
Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. J Obstet Gynaecol (2003) 0.79
Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver. Hepatol Res (2007) 0.79
Randomized Controlled Trial of Pancreaticojejunostomy versus Stapler Closure of the Pancreatic Stump During Distal Pancreatectomy to Reduce Pancreatic Fistula. Ann Surg (2016) 0.79
Primary epithelioid hemangioendothelioma of the retroperitoneum: report of a case. Surg Today (2012) 0.79
Expression of ETS-1 related to angiogenesis in uterine endometrium during the menstrual cycle. J Biomed Sci (2003) 0.79
Sectionectomy of the liver. J Hepatobiliary Pancreat Sci (2012) 0.78
Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers. Oncology (2007) 0.78